{"id":"W4413791590","doi":"10.1016/s2152-2650(25)02640-0","title":"MM-771: Daratumumab Plus Bortezomib, Lenalidomide, and Dexamethasone (D-VRd) in Patients With Newly Diagnosed Multiple Myeloma (NDMM): Subgroup Analysis of Transplant-ineligible (TIE) Patients in the Phase 3 CEPHEUS Study","year":2025,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Institute of Cancer Research; University of Alberta; University of Calgary","funders":"","keywords":"Lenalidomide; Daratumumab; Medicine; Bortezomib; Multiple myeloma; Dexamethasone; Oncology; Internal medicine; Subgroup analysis; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014713,0.0009991674,0.002282524,0.0005054472,0.0003220328,0.001210527,0.0005966512,0.0006255821,0.001419896],"category_scores_gemma":[0.001460457,0.0003931558,0.004189915,0.0007925463,0.0003472981,0.0007328277,0.0006681163,0.001359321,0.0001659403],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006269457,"about_ca_system_score_gemma":0.0007460827,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001528979,"about_ca_topic_score_gemma":0.004710974,"domain_scores_codex":[0.9992964,0.0002882089,0.00007159132,0.0001406862,0.00006475779,0.0001382119],"domain_scores_gemma":[0.9994099,0.0001722089,0.0001869388,0.00006608058,0.00002183243,0.0001431177],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6026774,0.001784794,0.3036274,0.001070108,0.03444673,0.0004090759,0.0002168785,0.002135979,0.006460246,0.0003105048,0.002642144,0.04421868],"study_design_scores_gemma":[0.1344297,0.0397689,0.7634664,0.0003060976,0.049262,0.0008370659,0.0006798441,0.003628609,0.001742798,0.001169016,0.004552735,0.0001567858],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9945942,0.004114227,0.00007792643,0.0001567628,0.00007145628,0.00006645066,0.0005241267,0.000008208719,0.0003866207],"genre_scores_gemma":[0.9973581,0.0009356003,0.000112858,0.0002081833,0.00008122138,0.00005913062,0.0009757973,0.000005790075,0.0002633885],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002282524,"threshold_uncertainty_score":0.007781029,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02306697003661301,"score_gpt":0.3389365604046721,"score_spread":0.3158695903680591,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}